Iain L Lamont Selected Research

Iain L Lamont Research Topics

13	Infections 06/2022 - 01/2007
9	Cystic Fibrosis (Mucoviscidosis) 11/2019 - 01/2007
2	Pseudomonas Infections 01/2021 - 12/2013
2	Persistent Infection 08/2013 - 01/2007
2	Wounds and Injuries (Trauma) 11/2011 - 11/2010
2	Starvation 09/2002 - 06/2001
1	Hypochromic Anemia (Chlorosis) 10/2019
1	Mycoses (Diseases, Fungus) 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Cross Infection (Nosocomial Infection) 01/2017
1	Cadaver (Cadavers) 01/2013

9	IronIBA 02/2021 - 06/2001
7	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 11/2018
4	pyoverdinIBA 02/2021 - 01/2007
3	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2021 - 01/2019
3	SiderophoresIBA 06/2014 - 06/2001
2	RNA (Ribonucleic Acid)IBA 11/2018 - 08/2013
2	Heme (Haem)IBA 06/2014 - 08/2013
2	Explosive Agents (Explosives)IBA 11/2011 - 11/2010
1	AminoglycosidesIBA 06/2022
1	LactamsIBA 12/2021
1	Ceftazidime (Fortum)FDA LinkGeneric 11/2019
1	Meropenem (Merrem)FDA LinkGeneric 11/2019
1	Tobramycin (Nebcin)FDA LinkGeneric 11/2019
1	NucleosidesIBA 01/2019
1	NucleotidesIBA 01/2017
1	Uric Acid (Urate)IBA 01/2013
1	AmmoniaIBA 01/2013
1	NAD (NADH)IBA 01/2013
1	formic acid (formate)IBA 01/2013
1	HypoxanthineIBA 01/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2013
1	MicronutrientsIBA 12/2011
1	Proteins (Proteins, Gene)FDA Link 10/2008

1	Therapeutics 12/2013